LA
SLXNW

Linden Advisors’s Silexion Therapeutics Corp Warrant SLXNW Stock Holding History

Linden Advisors’s Portfolio SLXNW Stock Details SLXNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$14K Hold
337,500
– – ﹤0.01% 363
2025
Q1 		$23.6K Hold
337,500
– – ﹤0.01% 281
2024
Q4 		$13.8K Hold
337,500
– – ﹤0.01% 244
2024
Q3 		$17.1K Buy
+337,500
New +$17.1K ﹤0.01% 232